Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pulse Biosciences (PLSE) Cash from Investing Activities (2020 - 2025)

Historic Cash from Investing Activities for Pulse Biosciences (PLSE) over the last 6 years, with Q3 2025 value amounting to -$62000.0.

  • Pulse Biosciences' Cash from Investing Activities fell 6315.79% to -$62000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$283000.0, marking a year-over-year decrease of 14608.7%. This contributed to the annual value of -$125000.0 for FY2024, which is 330.58% down from last year.
  • Per Pulse Biosciences' latest filing, its Cash from Investing Activities stood at -$62000.0 for Q3 2025, which was down 6315.79% from -$123000.0 recorded in Q2 2025.
  • Pulse Biosciences' 5-year Cash from Investing Activities high stood at $7.9 million for Q1 2021, and its period low was -$279000.0 during Q1 2022.
  • Moreover, its 5-year median value for Cash from Investing Activities was -$43000.0 (2023), whereas its average is $351894.7.
  • Its Cash from Investing Activities has fluctuated over the past 5 years, first soared by 9930.44% in 2021, then tumbled by 80000.0% in 2025.
  • Quarter analysis of 5 years shows Pulse Biosciences' Cash from Investing Activities stood at -$134000.0 in 2021, then skyrocketed by 69.4% to -$41000.0 in 2022, then fell by 4.88% to -$43000.0 in 2023, then fell by 23.26% to -$53000.0 in 2024, then fell by 16.98% to -$62000.0 in 2025.
  • Its Cash from Investing Activities was -$62000.0 in Q3 2025, compared to -$123000.0 in Q2 2025 and -$45000.0 in Q1 2025.